Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-alpha-acetyltransferase 15, NatA auxiliary subunit (NAA15) is the auxiliary subunit of the N-terminal acetyltransferase A (NatA) complex, one of the six major eukaryotic N-terminal acetyltransferase complexes. NAA15 partners with NAA10 (the catalytic subunit) to facilitate the transfer of an acetyl group from acetyl-CoA to the alpha-amino group of nascent polypeptides during translation, resulting in N-terminal acetylation, a modification critical for protein stability, subcellular localization, and interactions. NAA15 plays essential roles in vascular, hematopoietic, and neuronal development, and its deficiency impacts neurogenesis and can manifest in neurodevelopmental disorders, including intellectual disability and autism. Dysregulation of NAA15 expression has been implicated in various cancers, including papillary thyroid and gastric cancers[1][4][6][8]. NAA15 functions as part of larger multiprotein complexes and regulates activity together with other proteins such as HYPK and NAA50[2][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-alpha-acetyltransferase 15, NatA auxiliary subunit (NAA15).